Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sven N Reske

Showing results (11-20 of 89) with videos related to

Pageof 9
Sort By:
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 24, 2009
Improving anti-CD45 antibody radioimmunotherapy using a physiologically based pharmacokinetic modelPeter Kletting, Donald Bunjes, Sven N Reske, et al.
Medical Physics|October 8, 2003
ROC analysis for assessment of lesion detection performance in 3D PET: influence of reconstruction algorithmsGerhard Glatting, Christoph Werner, Sven N Reske, et al.
European Journal of Nuclear Medicine and Molecular Imaging|May 6, 2004
Biological characterisation of breast cancer by means of PETAndreas K Buck, Holger Schirrmeister, Torsten Mattfeldt, et al.
Anticancer Research|May 6, 2009
Pro-apoptosis and anti-proliferation effects of a recombinant dominant-negative survivin-T34A in human cancer cellsChangxian Shen, Weijin Liu, Andreas K Buck, et al.
Medical Physics|December 13, 2007
Choosing the optimal fit function: comparison of the Akaike information criterion and the F-testGerhard Glatting, Peter Kletting, Sven N Reske, et al.
European Journal of Nuclear Medicine and Molecular Imaging|August 13, 2002
A survey of PET activity in Germany during 1999Gunnar Brix, Dietmar Nosske, Gerhard Glatting, et al.
Journal of Cellular Biochemistry|September 30, 2008
Chromosome instability and tumor lethality suppression in carcinogenesisChangxian Shen, Yonggang Zhou, Jun Zhan, et al.
Cancer Biotherapy & Radiopharmaceuticals|November 25, 2003
Positron emission tomography (PET) for staging of solitary plasmacytomaHolger Schirrmeister, Andreas K Buck, Lothar Bergmann, et al.
FEBS Letters|March 26, 2003
Gene silencing by adenovirus-delivered siRNAChangxian Shen, Andreas K Buck, Xiangwei Liu, et al.
Case Reports in Medicine|April 17, 2010
Metronomic treatment with low-dose trofosfamide leads to a long-term remission in a patient with docetaxel-refractory advanced metastatic prostate cancerJochen Greiner, Rainer Küfer, Sven N Reske, et al.
Pageof 9

Showing results (11-20 of 89) with videos related to

Sort By:
Pageof 9
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 24, 2009
Improving anti-CD45 antibody radioimmunotherapy using a physiologically based pharmacokinetic modelPeter Kletting, Donald Bunjes, Sven N Reske, et al.
Medical Physics|October 8, 2003
ROC analysis for assessment of lesion detection performance in 3D PET: influence of reconstruction algorithmsGerhard Glatting, Christoph Werner, Sven N Reske, et al.
European Journal of Nuclear Medicine and Molecular Imaging|May 6, 2004
Biological characterisation of breast cancer by means of PETAndreas K Buck, Holger Schirrmeister, Torsten Mattfeldt, et al.
Anticancer Research|May 6, 2009
Pro-apoptosis and anti-proliferation effects of a recombinant dominant-negative survivin-T34A in human cancer cellsChangxian Shen, Weijin Liu, Andreas K Buck, et al.
Medical Physics|December 13, 2007
Choosing the optimal fit function: comparison of the Akaike information criterion and the F-testGerhard Glatting, Peter Kletting, Sven N Reske, et al.
European Journal of Nuclear Medicine and Molecular Imaging|August 13, 2002
A survey of PET activity in Germany during 1999Gunnar Brix, Dietmar Nosske, Gerhard Glatting, et al.
Journal of Cellular Biochemistry|September 30, 2008
Chromosome instability and tumor lethality suppression in carcinogenesisChangxian Shen, Yonggang Zhou, Jun Zhan, et al.
Cancer Biotherapy & Radiopharmaceuticals|November 25, 2003
Positron emission tomography (PET) for staging of solitary plasmacytomaHolger Schirrmeister, Andreas K Buck, Lothar Bergmann, et al.
FEBS Letters|March 26, 2003
Gene silencing by adenovirus-delivered siRNAChangxian Shen, Andreas K Buck, Xiangwei Liu, et al.
Case Reports in Medicine|April 17, 2010
Metronomic treatment with low-dose trofosfamide leads to a long-term remission in a patient with docetaxel-refractory advanced metastatic prostate cancerJochen Greiner, Rainer Küfer, Sven N Reske, et al.
Pageof 9